1. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER Cancer Statistics Review, 1975–2013. National Cancer Institute. Bethesda. http://seer.cancer.gov/csr/1975_2013/ . Based on November 2015 SEER data submission, posted to the SEER web site, April 2016.
2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30. doi: 10.3322/caac.21332 .
3. Valenca LB, Hirsch MS, Choueiri TK, Harshman LC. Clin Adv Hematol Oncol. 2015;13(5):308–13.
4. Beroukhim R, Brunet JP, Di Napoli A, et al. Patterns of gene expression and copy-number alterations in von-Hippel Lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res. 2009;69(11):4674–81. doi: 10.1158/0008-5472.CAN-09-0146 .
5. Sufan RI, Jewett MA, Ohh M. The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma. Am J Physiol Renal Physiol. 2004;287(1):F1–6.